Hangzhou Polymed Biopharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Hangzhou Polymed Biopharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia (NCT07137637) | Hangzhou Polymed Biopharmaceuticals, Inc. | 2026-04-10 |
Track Hangzhou Polymed Biopharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.